(Q35745765)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11021828%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

title

Antibody-mediated resolution of light chain-associated amyloid deposits (English)

1 reference

31 October 2019

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11021828%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

author name string

R Hrncic

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11021828%20AND%20SRC:MED&resulttype=core&format=json

1

1 reference

31 October 2019

D A Wolfenbarger

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11021828%20AND%20SRC:MED&resulttype=core&format=json

3

1 reference

31 October 2019

C L Murphy

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11021828%20AND%20SRC:MED&resulttype=core&format=json

4

1 reference

31 October 2019

M Schell

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11021828%20AND%20SRC:MED&resulttype=core&format=json

5

1 reference

31 October 2019

D T Weiss

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11021828%20AND%20SRC:MED&resulttype=core&format=json

6

1 reference

31 October 2019

A Solomon

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11021828%20AND%20SRC:MED&resulttype=core&format=json

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11021828%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

language of work or name

English

0 references

publication date

1 October 2000

1 reference

The American Journal of Pathology

31 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11021828%20AND%20SRC:MED&resulttype=core&format=json

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11021828%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

volume

157

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11021828%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

page(s)

1239-1246

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11021828%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

issue

4

1 reference

The resorption of amyloid under experimental conditions

31 October 2019

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850152

Autologous stem cell transplantation for AL amyloidosis: a standard therapy?

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850152

Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850152

Transgenic mouse model of AA amyloidosis

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850152

Physicochemical consequences of amino acid variations that contribute to fibril formation by immunoglobulin light chains

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850152

Intermediate-dose intravenous melphalan and blood stem cells mobilized with sequential GM+G-CSF or G-CSF alone to treat AL (amyloid light chain) amyloidosis

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850152

High-dose therapy in multiple myeloma and primary amyloidosis: an overview

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850152

Amyloidosis: a review of recent diagnostic and therapeutic developments

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850152

27 July 2018

The systemic amyloidoses

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850152

Biology and therapy of immunoglobulin deposition diseases

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850152

The hydroxyl radical: from chemistry to human disease.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850152

Treatment of 100 patients with primary amyloidosis: a randomized trial of melphalan, prednisone, and colchicine versus colchicine only.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850152

Elastase and oxygen radicals: synergistic interactions

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850152

Gene targeting yields a CD18-mutant mouse for study of inflammation.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850152

Treatment of primary amyloidosis.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850152

Primary systemic amyloidosis: clinical and laboratory features in 474 cases.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850152

Amyloidosis: prognosis and treatment

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850152

Interaction of the anthracycline 4'-iodo-4'-deoxydoxorubicin with amyloid fibrils: inhibition of amyloidogenesis

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850152

The characterization of soluble amyloid prepared in water

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850152

Immunologic studies of water-soluble human amyloid fibrils. Comparative studies of eight amyloid preparations

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850152

Response of primary hepatic amyloidosis to melphalan and prednisone: a case report and review of the literature

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850152

Sulfated glycosaminoglycans: a common constituent of all amyloids?

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850152

Rapid reversal of nephrotic syndrome due to primary systemic AL amyloidosis after VAD and subsequent high-dose chemotherapy with autologous stem cell support.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850152

Prognostic factors for survival and response after high-dose therapy and autologous stem cell transplantation in systemic AL amyloidosis: a report on 21 patients.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850152

Distinctive serologic, chemical, and molecular properties of human lambda IV light chains.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850152

Serum amyloid P component prevents proteolysis of the amyloid fibrils of Alzheimer disease and systemic amyloidosis

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850152

Arresting amyloidosis in vivo using small-molecule anionic sulphonates or sulphates: implications for Alzheimer's disease.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850152

A trial of three regimens for primary amyloidosis: colchicine alone, melphalan and prednisone, and melphalan, prednisone, and colchicine

25 September 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2964639-1

Treatment of AL-amyloidosis with dexamethasone plus alpha interferon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2964639-1

The resolution of amyloid substance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2964639-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2964639-1

Macromolecular properties of glycosaminoglycans in primary AL amyloid fibril extracts of lymphoid tissue origin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2964639-1

A modified method for the colorimetric determination of heparin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2964639-1

Novel immunization protocol and ELISA screening methods used to obtain and characterize monoclonal antibodies specific for human light chain variable-region subgroups

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2964639-1

Production and immunodiagnostic applications of antihuman light chain monoclonal antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2964639-1

Thermodynamic instability of human lambda 6 light chains: correlation with fibrillogenicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2964639-1

On the essential involvement of neutrophils in the immunopathologic disease: herpetic stromal keratitis

7 January 2021

1 reference

12 December 2020

Treatment of AL amyloidosis with 4'-lodo-4'-deoxydoxorubicin: an update

1 reference

12 December 2020

Effect of poly(vinylsulfonate) on murine AA amyloid: a high-resolution ultrastructural study

1 reference

12 December 2020

Immunochemical typing of amyloid deposits after microextraction from biopsies

1 reference

12 December 2020

New drug therapy of amyloidoses: resorption of AL-type deposits with 4'-iodo-4'-deoxydoxorubicin

1 reference

12 December 2020

Bence-Jones proteins and light chains of immunoglobulins. I. Formation and characterization of amino-terminal (variant) and carboxyl-terminal (constant) halves

1 reference

12 December 2020

Dose-intensive melphalan with blood stem-cell support for the treatment of AL (amyloid light-chain) amyloidosis: survival and responses in 25 patients

1 reference

12 December 2020